Leslie Walker

Facing mounting financial pressures, insurance companies are changing the prescription drug coverage available to many consumers in Medicare Part D.

A new pair of academic studies offers evidence that Medicaid saves lives. So, what's at stake if the major Medicaid reforms and deep cuts that were approved by House Republicans make it through Congress?

Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep trouble.

America's health care leaders have spent two decades searching for a way to keep costly, complicated patients from cycling in and out of the hospital dozens of times a year. What have they learned?

A new bipartisan bill takes aim at a $500 billion government health care mess. Will it make care better for some of the country's sickest, poorest patients?

A bipartisan group of lawmakers agree: Medicare and Medicaid are failing 12 million of the country's most vulnerable patients.

Whats a fair price to pay for prescription drugs? Medicare will soon face this and other tough questions when it begins historic price negotiations with drugmakers.

The rapid growth of private Medicare Advantage plans is raising questions about what care could and should look like for all 80 million people expected to be on Medicare by 2030.

A federal pilot project tests handing the reins of some hospice care over to private insurers. The experiment, which began in 2021, could ultimately transform the end of life care available to millions of Americans.

After 20 years and $200 billion in revenue, Humira an injectable treatment for autoimmune conditions like rheumatoid arthritis is losing its monopoly.